David A. Siegel Nuwellis, Inc. Transaction History

Two Sigma Advisers, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.56 - $2147.95 $2,352 - $9.02 Million	-4,200 Reduced 22.7%	14,300 $8,000
Q2 2022 Aug 15, 2022	SELL	$0.48 - $1.12 $1,776 - $4,144	-3,700 Reduced 16.67%	18,500 $11,000
Q1 2022 May 16, 2022	SELL	$0.85 - $1.27 $17,510 - $26,162	-20,600 Reduced 48.13%	22,200 $22,000
Q4 2021 Feb 14, 2022	BUY	$1.13 - $2.26 $48,363 - $96,727	42,800 New	42,800 $49,000

Ticker NUWE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,531,600
Market Cap $36.3M
Description
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex ...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.